Skip to main content
TipRanks
Go Ultimate75% OFF

Mark J. Holdbrook Insider Profile

4 Followers

Mark J. Holdbrook, V.P., Clinical Affairs at Tarsus Pharmaceuticals, holds 3.19K shares in Tarsus Pharmaceuticals (Ticker: TARS). Most recently, Mark J. Holdbrook Sold 386 shares of Tarsus Pharmaceuticals on Mar 21, 2023 for an estimated value of $4.99K.

Mark J. Holdbrook's Trading History

TARS
Tarsus Pharmaceuticals
Mar 21, 2023V.P., Clinical AffairsInformative Sell4.99K$256.17K
TARS
Insider Shares: 3.19K (0.01%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 21, 2023Informative Sell$4.99K386$12.93―
Mar 17, 2023Uninformative Buy$33.88K2,466$13.74―

You May Also Like

Mark J. Holdbrook insider profile FAQ

What stocks does Mark J. Holdbrook hold?
Mark J. Holdbrook holds: TARS stocks.
What was Mark J. Holdbrook’s latest transaction?
Mark J. Holdbrook’s latest transaction was an Informative Sell of $4.99K.
What is Mark J. Holdbrook's role in Tarsus Pharmaceuticals?
Mark J. Holdbrook's role in Tarsus Pharmaceuticals is V.P., Clinical Affairs.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.